Scarica l'app Stockscreener
43.45
2.05%
-0.91
Dopo l'orario di chiusura:
43.90
0.45
+1.04%
Precedente Chiudi:
$44.36
Aprire:
$44.41
Volume 24 ore:
1.32M
Relative Volume:
1.13
Capitalizzazione di mercato:
$3.12B
Reddito:
-
Utile/perdita netta:
$-299.62M
Rapporto P/E:
-9.3162
EPS:
-4.6639
Flusso di cassa netto:
$-241.73M
1 W Prestazione:
+7.74%
1M Prestazione:
+8.73%
6M Prestazione:
+40.16%
1 anno Prestazione:
+101.25%
Intervallo 1D:
$42.49
$44.55
Intervallo di 1 settimana:
$39.57
$47.00
Portata 52W:
$18.76
$56.05
Vera Therapeutics Inc Stock (VERA) Company Profile
Nome
Vera Therapeutics Inc
Settore
Industria
Telefono
650-770-0077
Indirizzo
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
43.45 | 3.18B | 0 | -299.62M | -241.73M | -4.6639 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-11 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-10-16 | Iniziato | BofA Securities | Buy |
| 2025-08-04 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2025-01-28 | Iniziato | Goldman | Buy |
| 2024-11-21 | Iniziato | Wells Fargo | Overweight |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-01-25 | Iniziato | Oppenheimer | Outperform |
| 2024-01-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Iniziato | Raymond James | Outperform |
| 2023-11-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-16 | Iniziato | Guggenheim | Buy |
| 2023-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-01-04 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-07-12 | Iniziato | JP Morgan | Overweight |
| 2022-05-02 | Iniziato | H.C. Wainwright | Buy |
| 2022-04-19 | Iniziato | Wedbush | Outperform |
Mostra tutto
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Fordyce, Vera Therapeutics CEO, sells $1m in VERA stock - Investing.com
Polycythemia Vera Market: Rapid Increment Driven by Innovation - openPR.com
Vertex Sues Former Exec To Block Move To Rival - Law360
VERA (NASDAQ: VERA) director sells 16,925 shares for $710,577.51 — Form 144 - Stock Titan
Panic Selling: Is Vera Therapeutics Inc vulnerable to short sellersQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
Discipline and Rules-Based Execution in VERA Response - Stock Traders Daily
Vera Therapeutics Announces Inducement Grants - National Today
Vera Therapeutics (VERA) Valuation Check After Recent Share Price Rebound - Sahm
Risk Check: Does Vera Therapeutics Inc align with a passive investing strategyTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Vera Therapeutics stock rises after crossing above key SMA - Intellectia AI
Published on: 2026-04-11 13:37:36 - baoquankhu1.vn
Can Vera Therapeutics Inc deliver consistent EPS growth2026 Bull vs Bear & High Yield Stock Recommendations - baoquankhu1.vn
Vera Therapeutics Grants Inducement Awards to New Employees Under 2024 Inducement Plan - Quiver Quantitative
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Vera Therapeutics issues stock awards to 89 new employees - Stock Titan
Is Vera Therapeutics (VERA) Still Attractive After An 87% One Year Share Price Surge - Yahoo Finance
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Board of Vera Therapeutics (VERA) seeks votes on directors, auditor and say-on-pay - Stock Titan
Is It Too Late To Consider Vera Therapeutics (VERA) After Its Recent Share Price Surge? - Sahm
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight - GlobeNewswire Inc.
BofA Initiates Coverage of Vera Therapeutics (VERA) With a Buy Rating - MSN
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vera Therapeutics Adds Experienced Legal Chief As Shares Trade Below Targets - Sahm
Behavioral Patterns of VERA and Institutional Flows - Stock Traders Daily
Point72 (NASDAQ: VERA) reports 1.7% holding, 1.23M shares disclosed - Stock Titan
Big Picture: What is the next catalyst for Vera Therapeutics Inc2026 Support & Resistance & Technical Pattern Based Signals - baoquankhu1.vn
Day Trade: How cyclical is Vera Therapeutics Incs revenue stream2026 News Drivers & Technical Pattern Based Buy Signals - baoquankhu1.vn
Is Vera Therapeutics (VERA) Pricing Reflect Its DCF Upside After Recent Share Price Weakness - Sahm
VERA SEC FilingsVera Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
New Vera legal chief gets 56,850 options and 42,403 RSUs - Stock Titan
Vanguard disaggregates holdings; Vera Therapeutics (VERA) shows 0 shares reported - Stock Titan
Equity grants to Vera Therapeutics (VERA) Chief Legal Officer detailed in Form 4 - Stock Titan
Chief Legal Officer reports initial insider status at Vera Therapeutics (VERA) - stocktitan.net
Calif. Biotech Firm Vera Taps Vaxcyte Ex-GC As New CLO - Law360
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer By Investing.com - Investing.com Canada
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer - Investing.com
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer - The Manila Times
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock advances on promising Phase 3 data for atacicept in IgA nephropathy, boostin - AD HOC NEWS
Why Vera Therapeutics Shares Are Sinking Today - TipRanks
(VERA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Investment Firm Boosts Vera Therapeutics Holding to $41.75M in 2026News and Statistics - IndexBox
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year - The Motley Fool
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year - Bitget
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics - National Today
Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Is Suddenly Taking Off - TipRanks
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Vera Therapeutics Inc Azioni (VERA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):